Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Compass Therapeutics is a clinical-stage biopharmaceutical company focused on developing antibody-based immuno-oncology therapeutics. Its pipeline includes bispecific antibodies targeting tumor angiogenesis, immune checkpoints, and tumor microenvironment modulation. The company aims to treat various solid tumors by enhancing immune responses and disrupting tumor blood supply, leveraging proprietary technologies for antibody discovery, engineering, and manufacturing.
This description was generated via AI from an annual report. Updated about 1 year ago.